Concepedia

Hans Heemskerk

HH

10

Publications

914

Citations

10

H-Index

2008

Active since

Affiliations

Leiden University Medical Center(Current)

ProQR Therapeutics (Netherlands)

University of Ferrara

Hans Heemskerk is an author at Leiden University Medical Center specializing in medicine, systems biology, and molecular biology.

Top concepts

Publications per year

2008–2013

10

Publications

10

Phage display screening without repetitious selection rounds

Peter A.C. ’t Hoen, Silvana M.G. Jirka, Bradley R. ten Broeke et al. · Analytical Biochemistry · 2011 · 169 citations · Full text

, , +22

<i>In vivo</i> comparison of 2′‐<i>O</i>‐methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping

Hans Heemskerk, C.L. de Winter, Sjef J. de Kimpe et al. · The Journal of Gene Medicine · 2009 · 169 citations · Full text

Guidelines for Antisense Oligonucleotide Design and Insight Into Splice-modulating Mechanisms

Annemieke Aartsma‐Rus, Laura Van de Vliet, Marscha Hirschi et al. · Molecular Therapy · 2008 · 145 citations · Full text

Preclinical PK and PD Studies on 2′-O-Methyl-phosphorothioate RNA Antisense Oligonucleotides in the mdx Mouse Model

Hans Heemskerk, Christa de Winter, Petra van Kuik et al. · Molecular Therapy · 2010 · 137 citations · Full text

Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double‐knockout mice

Maaike van Putten, Margriet Hulsker, Courtney S. Young et al. · The FASEB Journal · 2013 · 113 citations · Full text

Rows per page

1–5 of 10